BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7962122)

  • 1. Adaptation of EGF receptor signal transduction to three-dimensional culture conditions: changes in surface receptor expression and protein tyrosine phosphorylation.
    Mansbridge JN; Ausserer WA; Knapp MA; Sutherland RM
    J Cell Physiol; 1994 Nov; 161(2):374-82. PubMed ID: 7962122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of tyrosine phosphatases in the effects of cell-cell contact and microenvironments on EGF-stimulated tyrosine phosphorylation.
    Mansbridge JN; Knüchel R; Knapp AM; Sutherland RM
    J Cell Physiol; 1992 Jun; 151(3):433-42. PubMed ID: 1284249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient.
    Gross ME; Zorbas MA; Danels YJ; Garcia R; Gallick GE; Olive M; Brattain MG; Boman BM; Yeoman LC
    Cancer Res; 1991 Mar; 51(5):1452-9. PubMed ID: 1847663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells.
    Suárez Pestana E; Tenev T; Gross S; Stoyanov B; Ogata M; Böhmer FD
    Oncogene; 1999 Jul; 18(28):4069-79. PubMed ID: 10435588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F; Goldstein BJ
    J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.
    Castagnola J; MacLeod C; Sunada H; Mendelsohn J; Taetle R
    J Cell Physiol; 1987 Sep; 132(3):492-500. PubMed ID: 3498729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
    Gardner DP; Shimizu N
    J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
    Wang Z; Wang M; Carr BI
    J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites.
    Soler C; Alvarez CV; Beguinot L; Carpenter G
    Oncogene; 1994 Aug; 9(8):2207-15. PubMed ID: 8036006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
    Wang X; Weng LP; Yu Q
    Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
    Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
    J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbol ester reduces phosphorylation of epidermal growth factor receptor in pancreatic cancer cells by activation of a tyrosine phosphatase.
    Ho JJ; Farrelly ER; Kim YS
    Biochem Biophys Res Commun; 1999 Nov; 265(3):728-33. PubMed ID: 10600488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor.
    Harper ME; Goddard L; Glynne-Jones E; Assender J; Dutkowski CM; Barrow D; Dewhurst OL; Wakeling AE; Nicholson RI
    Prostate; 2002 Jun; 52(1):59-68. PubMed ID: 11992620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor expression and function control cytotoxic responsiveness to tumor necrosis factor in ME-180 squamous carcinoma cells.
    Donato NJ; Yan DH; Hung MC; Rosenblum MG
    Cell Growth Differ; 1993 May; 4(5):411-9. PubMed ID: 8518234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor: potential interaction with epidermal growth factor receptor.
    Perez M; Haschke B; Donato NJ
    Oncogene; 1999 Jan; 18(4):967-78. PubMed ID: 10023672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular distribution and biological activity of epidermal growth factor receptors in A431 cells are influenced by cell-cell contact.
    Lichtner RB; Schirrmacher V
    J Cell Physiol; 1990 Aug; 144(2):303-12. PubMed ID: 2380256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T; Ma J; Cao X
    Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation.
    Reynolds AR; Tischer C; Verveer PJ; Rocks O; Bastiaens PI
    Nat Cell Biol; 2003 May; 5(5):447-53. PubMed ID: 12717446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
    Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
    J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.